Showing results (1-10 of 87) with videos related to
Sort By:
Pageof 9
Expert Review of Anticancer Therapy|July 13, 2002
Pemetrexed: a multitargeted antifolate (ALIMTA, LY-231514)Robert J Jones, Christopher J TwelvesNature Reviews. Cancer|June 23, 2007
Targeting the protein kinase C family: are we there yet?Helen J Mackay, Christopher J TwelvesJournal of Public Health (Oxford, England)|February 1, 2013
A qualitative investigation of the motivations, experiences and views of female sunbed users under the age of 18 in EnglandJeffrey R Lake, Catherine S Thomson, Christopher J Twelves, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2011
Immune recruitment and therapeutic synergy: keys to optimizing oncolytic viral therapy?Jay D Naik, Christopher J Twelves, Peter J Selby, et al.Physiotherapy Theory and Practice|February 26, 2021
Blind and partially sighted physiotherapy in the United Kingdom. A century of development, success and challenge. Will it still belong?Robert J JonesBreast Cancer Research : BCR|April 11, 2013
Is TIMP-1 immunoreactivity alone or in combination with other markers a predictor of benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial?Alison F Munro, Annette Bartels, Eva Balslev, et al.European Urology Focus|June 9, 2024
Toxicities of Novel Agents for the Treatment of Advanced Bladder CancerSamuel McInerney, Robert J JonesFuture Oncology (London, England)|October 6, 2015
Emerging treatments for recurrent prostate cancerCatherine Hanna, Robert J JonesBreast Cancer Research : BCR|June 24, 2003
8th international conference: primary therapy of early breast cancer, St Gallen, Switzerland, March 12-15 2003Hilary Glen, Robert J JonesBreast Cancer Research and Treatment|January 20, 2016
Characterizing and quantifying the effects of breast cancer therapy using mathematical modelingWalter M Gregory, Christopher J Twelves, Richard Bell, et al.Pageof 9